Chimerix Inc. said Thursday it plans to conduct a clinical trial of its experimental antiviral drug in patients with the Ebola virus.
from WSJ.com: US Business http://ift.tt/1vAaPKV
via IFTTT
from WSJ.com: US Business http://ift.tt/1vAaPKV
via IFTTT
No comments:
Post a Comment